Enlivex Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 1.78 M | $1.73 M | -19.30% | 8.14% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 669.01 K | $649.07 K | 5.55% | 3.06% |
| MORGAN STANLEY | 05/15/2025 | 230.69 K | $223.81 K | -14.45% | 1.05% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 181.29 K | $175.89 K | 14.02% | 0.83% |
| JANE STREET GROUP, LLC | 05/19/2025 | 80.76 K | $78.35 K | 527.35% | 0.37% |
| CITADEL ADVISORS LLC | 05/15/2025 | 70.14 K | $68.05 K | 100.00% | 0.32% |
| CITADEL ADVISORS LLC | 05/15/2025 | 44.30 K | $42.98 K | 275.42% | 0.20% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 28.39 K | $27.54 K | 26.96% | 0.13% |
| SIGMA INVESTMENT COUNSELORS INC | 04/30/2025 | 28.00 K | $27.17 K | 0.00% | 0.13% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 17.45 K | $17.00 K | 100.00% | 0.08% |
| NEUBERGER BERMAN GROUP LLC | 05/13/2025 | 14.00 K | $13.58 K | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 10.83 K | $10.51 K | -2.92% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 10.42 K | $10.11 K | 0.00% | 0.05% |
| HRT FINANCIAL LP | 05/15/2025 | 10.18 K | $9.00 K | -39.70% | 0.05% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 9.18 K | $8.91 K | 0.00% | 0.04% |
| CITADEL ADVISORS LLC | 05/15/2025 | 7.10 K | $6.89 K | -21.98% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 6.74 K | $6.53 K | 847.54% | 0.03% |
| SIGNATUREFD, LLC | 05/02/2025 | 5.00 K | $4.85 K | 0.00% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/13/2025 | 2.50 K | $2.43 K | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.91 K | $1.86 K | -25.39% | 0.01% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 1.06 K | $1.00 K | -68.42% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/15/2025 | 1.02 K | $985 | 0.00% | 0.00% |
| BFSG, LLC | 04/18/2025 | 1.00 K | $971 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 05/15/2025 | 1.00 K | $970 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 220 | $213 | -79.13% | 0.00% |
| RED TORTOISE LLC | 04/25/2025 | 150 | $146 | 0.00% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 16 | $16 | 0.00% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 04/23/2025 | 0 | $0 | -100.00% | 0.00% |
| ARS WEALTH ADVISORS GROUP, LLC | 04/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enlivex Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.78 M
MILLENNIUM MANAGEMENT LLC: 669,008
MORGAN STANLEY: 230,685
RENAISSANCE TECHNOLOGIES LLC: 181,289
JANE STREET GROUP, LLC: 80,759
CITADEL ADVISORS LLC: 70,136
14.45% of Enlivex Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 3.18 M shares in the last 24 months. This purchase volume represents approximately $3.31 M in transactions.